Orquest Healos
This article was originally published in The Gray Sheet
Executive Summary
Bone graft substitute is as safe and effective as an autograft in spinal fusion procedures, according to results of a randomized, 29-patient, two-center European study. The findings, presented at Eurospine 1999 on Sept. 11, show that 10 of 13 Healos patients and 13 of 16 autograft patients were considered successfully treated at 12 months. Use of a substitute for autograft in spinal fusions is expected to avoid difficulties related to the harvesting procedure - including an increase in surgery time, longer hospital stays and post-operative disability. U.S. clinical trials of Healos are under way